BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37046726)

  • 21. Bioinformatics analysis of multi-omics data identifying molecular biomarker candidates and epigenetically regulatory targets associated with retinoblastoma.
    Zeng Y; He T; Liu J; Li Z; Xie F; Chen C; Xing Y
    Medicine (Baltimore); 2020 Nov; 99(47):e23314. PubMed ID: 33217867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma.
    Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J
    Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction and Validation of Prognostic Regulation Network Based on RNA-Binding Protein Genes in Lung Squamous Cell Carcinoma.
    Zhao S; Liu Q; Li J; Hu C; Cao F; Ma W; Gao J
    DNA Cell Biol; 2021 Dec; 40(12):1563-1583. PubMed ID: 34931870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
    Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
    BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinoma.
    Gao X; Wu Y; Yu W; Li H
    Oncotarget; 2016 Dec; 7(49):81670-81679. PubMed ID: 27835574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
    Yang Y; Wang M; Liu B
    J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Competitive Endogenous RNA Network Construction and Comparison of Lung Squamous Cell Carcinoma in Smokers and Nonsmokers.
    Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang X; Li J; Li J; Sun C
    Dis Markers; 2019; 2019():5292787. PubMed ID: 31885738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High Expression Levels of CDK1 and CDC20 in Patients With Lung Squamous Cell Carcinoma are Associated With Worse Prognosis.
    Deng H; Hang Q; Shen D; Ying H; Zhang Y; Qian X; Chen M
    Front Mol Biosci; 2021; 8():653805. PubMed ID: 34307447
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification of crucial regulatory relationships between long non-coding RNAs and protein-coding genes in lung squamous cell carcinoma.
    Wu X; Ruan L; Yang Y; Mei Q
    Mol Cell Probes; 2016 Jun; 30(3):146-52. PubMed ID: 26928440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In silico analysis revealed the potential circRNA-miRNA-mRNA regulative network of non-small cell lung cancer (NSCLC).
    Balasundaram A; C GPD
    Comput Biol Med; 2023 Jan; 152():106315. PubMed ID: 36495751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor mutation burden (TMB)-associated signature constructed to predict survival of lung squamous cell carcinoma patients.
    Yan D; Chen Y
    Sci Rep; 2021 Apr; 11(1):9020. PubMed ID: 33907270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene regulation and prognostic indicators of lung squamous cell carcinoma: TCGA-derived miRNA/mRNA sequencing and DNA methylation data.
    Shen Y; Pan X; Yang J
    J Cell Physiol; 2019 Dec; 234(12):22896-22910. PubMed ID: 31169310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of prognostically relevant gene signatures in lung squamous cell carcinoma by Lung Cancer Explorer.
    Wang Y; Shen J; Huang J
    Transl Cancer Res; 2021 May; 10(5):2009-2022. PubMed ID: 35116523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Value and Potential Mechanism of miRNA-33a-5p in Lung Squamous Cell Carcinoma.
    Wang XM; Chen SW; Chen G; Zhou HF; Gan TQ; Zeng JJ; Li ZY
    Anal Cell Pathol (Amst); 2021; 2021():6614331. PubMed ID: 34888137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific Lung Squamous Cell Carcinoma Prognosis-Subtype Distinctions Based on DNA Methylation Patterns.
    Huang G; Zhang J; Gong L; Liu D; Wang X; Chen Y; Guo S
    Med Sci Monit; 2021 Mar; 27():e929524. PubMed ID: 33661858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraits.
    Pal B; Chen Y; Bert A; Hu Y; Sheridan JM; Beck T; Shi W; Satterley K; Jamieson P; Goodall GJ; Lindeman GJ; Smyth GK; Visvader JE
    Breast Cancer Res; 2015 Jun; 17(1):85. PubMed ID: 26080807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrative analysis of DNA methylation-driven genes for the prognosis of lung squamous cell carcinoma using MethylMix.
    Li R; Yin YH; Jin J; Liu X; Zhang MY; Yang YE; Qu YQ
    Int J Med Sci; 2020; 17(6):773-786. PubMed ID: 32218699
    [No Abstract]   [Full Text] [Related]  

  • 38. Bioinformatics analyses of the differences between lung adenocarcinoma and squamous cell carcinoma using The Cancer Genome Atlas expression data.
    Sun F; Yang X; Jin Y; Chen L; Wang L; Shi M; Zhan C; Shi Y; Wang Q
    Mol Med Rep; 2017 Jul; 16(1):609-616. PubMed ID: 28560415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNAs associated with lung squamous cell carcinoma: New prognostic biomarkers and therapeutic targets.
    Qi L; Gao C; Feng F; Zhang T; Yao Y; Wang X; Liu C; Li J; Li J; Sun C
    J Cell Biochem; 2019 Nov; 120(11):18956-18966. PubMed ID: 31241205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction of Potential Glioblastoma Multiforme-Related miRNA-mRNA Regulatory Network.
    Lou W; Ding B; Xu L; Fan W
    Front Mol Neurosci; 2019; 12():66. PubMed ID: 30971889
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.